Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
La Jolla Labs leverages proprietary bioinformatics, machine learning, and automation to develop predictive tools for oligonucleotide therapeutics. Their focus includes high-throughput ASO screening and a robust AI-driven platform for RNA-targeted drug discovery. The company’s therapeutic programs are primarily at the preclinical stage with a focus on neurological and rare diseases as well as oncology. They also provide industry-leading software tools such as LJSplice to support efficient design of splicing strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on La Jolla Labs.